Analysis for ChemoMetec
Description & usage
ChemoMetec develops analytical instruments for cell counting and quality control in biotech and pharma workflows. The company benefits from deep specialization and structural growth in biopharma research and manufacturing. Key drivers are instrument sales, consumables revenue, innovation pace, and margin quality.
Basic info
- Symbol
- CHEMM.CO
- Type
- Stock
- Region
- Europe
- Sector
- Industrials
- Available history
- 11.1 years
- Last trading day
- 04/01/2026
Basic info
- Symbol
- CHEMM.CO
- Type
- Stock
- Region
- Europe
- Sector
- Industrials
- Available history
- 11.1 years
- Last trading day
- 04/01/2026
Market context
- DXY
- 120.89
- US 10Y Real
- 1.99%
- Fed Balance
- $6.68T
- EZ HICP
- 2.0%
- ECB Rate
- 4.25%
- Bund 10Y
- 3.03%
- VIX
- 24.54
- HY OAS
- 3.17%
- Brent
- $121.88
- Core HICP
- 2.3%
- DE 2Y
- 2.62%
- EZ PMI
- –
Score overview
The overall score combines Performance, Stability and Trend into one comparable value.
Market context
- DXY
- 120.89
- US 10Y Real
- 1.99%
- Fed Balance
- $6.68T
- EZ HICP
- 2.0%
- ECB Rate
- 4.25%
- Bund 10Y
- 3.03%
- VIX
- 24.54
- HY OAS
- 3.17%
- Brent
- $121.88
- Core HICP
- 2.3%
- DE 2Y
- 2.62%
- EZ PMI
- –
Analysis summary
Technical asset picture
ChemoMetec (CHEMM.CO) currently has a total score of 26 points, placing it in the weak range. The score is made up of Performance (45), Stability (11) and Trend (3). The profile is clearly uneven: Performance stands out while Trend lags.
Performance scores 45 points (neutral). Key strength: 10Y return at 702.6 %. Weaker metric: 1Y return at -38.6 %. This suggests stronger long-term than short-term performance.
Stability scores 11 points (very weak). Key strength: CAGR/drawdown ratio at 0.29. Main drag: max drawdown (1Y) at -70.1 %. Higher Stability points are better and typically reflect calmer swings and smaller drawdowns-but prices can still fall.
Trend scores 3 points (very weak). Trend signals are mostly negative right now. Least weak metric: relative strength (12M) at -28.8 %. Main drag: Price is about 29.2 % below SMA50.
Overall, the profile has a clear strength in Performance, while Trend is the main limiter. On a metric level, 10Y return stands out, while SMA50 distance is the main weak spot.
Current market backdrop
The backdrop currently looks mixed and rather restrictive.
A strong US dollar currently paints a mixed risk picture.
High US real yields and elevated long yields lean toward a restrictive rate backdrop.
What that typically means here
For this asset type, the current backdrop looks mixed rather than clearly directional.
Note: Euro area PMI was not used actively in the effect logic.
Historical evaluation and qualitative market context only, not investment advice.
Price chart
Use the chart to read recent price behavior before drilling into metrics.
Scores and metrics
Explore the overall score, the three pillar scores, and the metrics behind them.